Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients
Australasian Journal of Dermatology · 2023
DOI: 10.1111/ajd.14138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2023. Verfasst von Peter Foley und 13 weiteren Autor:innen. Beteiligte Einrichtung: Skin Health Institute, Carlton, Victoria, Australia. Hauptthemen laut MEDLINE: Quality of Life, Psoriasis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals.
Abstract (Originalsprache)
Background
Over the last decade, the treatment landscape for moderate–severe psoriasis has rapidly evolved. The Australasian College of Dermatologists sought to review and update previously published treatment goals for moderate–severe psoriasis.
Methods
A modified Delphi approach was used. Comprehensive literature review and guideline evaluation resulted in the development of statements and other questions to establish current clinical practices. Two rounds of anonymous voting were undertaken, with a collaborative meeting held in between to discuss areas of discordance. Overall, consensus was defined as achievement of ≥75% agreement in the range 7–9 on a 9‐point scale (1 strongly disagree; 9 strongly agree).
Results
Consensus was achieved on 26/29 statements in round 1 and a further 20 statements in round 2. There was strong agreement to expanding the classification/definition of psoriasis severity by including a choice of metrics, incorporating quality of life measures, and widening the scope of high‐impact sites. Consensus was also reached on revised treatment response criteria, which were then incorporated into a new treatment algorithm. There was discordance with the current requirement to undertake a trial with established systemic agents before accessing targeted therapy.
Conclusion
The ability of new targeted treatment options to change the narrative in psoriasis patient care can only be properly realised if challenges to timely and equitable access are addressed. The proposed framework for the assessment, classification and management of moderate–severe psoriasis aligns with international recommendations. Its adoption into Australian clinical practice is hoped to improve treatment outcomes and patients' satisfaction with their care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Skin Health Institute, Carlton, Victoria, Australia.
- Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
- The University of Melbourne, Melbourne, Victoria, Australia.
- Fremantle Dermatology, Fremantle, Western Australia, Australia.
- The University of Western Australia, Nedlands, Western Australia, Australia.
- Kareena Private Hospital, Ramsay Surgical Centre, Miranda, New South Wales, Australia.
ORCID-Profile: Peter Foley, Kurt Gebauer, John Sullivan, Erin McMeniman, Stephen Shumack, Jonathan Ng, Amelia James, Morton Rawlin, Shireen Sidhu, Dev Tilakaratne, Murray Turner, Peter Nash, Christopher Baker
Förderung
- Janssen Pharmaceuticals
Zitieren
APA
Foley, P., Gebauer, K., Sullivan, J., McMeniman, E., Shumack, S., Ng, J., James, A., Rawlin, M., Sidhu, S., Tilakaratne, D., Turner, M., Radulski, B., Nash, P., & Baker, C. (2023). Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14138
Vancouver
Foley P, Gebauer K, Sullivan J, McMeniman E, Shumack S, Ng J, et al. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients. Australasian Journal of Dermatology. 2023. doi:10.1111/ajd.14138
BibTeX
@article{Foley2023,
author = {Foley, Peter and Gebauer, Kurt and Sullivan, John and McMeniman, Erin and Shumack, Stephen and Ng, Jonathan and James, Amelia and Rawlin, Morton and Sidhu, Shireen and Tilakaratne, Dev and Turner, Murray and Radulski, Barbara and Nash, Peter and Baker, Christopher},
title = {Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients},
journal = {Australasian Journal of Dermatology},
year = {2023},
doi = {10.1111/ajd.14138}
}
EUVIMED